Homeostatic regulation of marginal zone B cells by invariant natural killer T cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wen, Xiangshu ^a   Yang, Jun Qi ^b,c   Kim, Peter J ^a   Singh, Ram Raj ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL ADHESION; CELL DEATH; CONTROLLED STUDY; FOLLICULAR B LYMPHOCYTE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MARGINAL ZONE B CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; ANIMAL; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CYTOLOGY; HOMEOSTASIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY;

MUS;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CELL DEATH; CELL PROLIFERATION; HOMEOSTASIS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS;

EID: 80055040434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026536     Document Type: Article

References (56)

1. Martin F, Kearney JF, (2002) Marginal-zone B cells. Nat Rev Immunol 2: 323-335.
2. Allman D, Pillai S, (2008) Peripheral B cell subsets. Curr Opin Immunol 20: 149-157.
3. Balazs M, Martin F, Zhou T, Kearney J, (2002) Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
4. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG, (2008) Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9: 54-62.
5. Attanavanich K, Kearney JF, (2004) Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 172: 803-811.
6. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, et al. (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 160: 3121-3127.
7. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, et al. (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863-865.
8. Porcelli SA, Modlin RL, (1999) The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17: 297-329.
9. Brigl M, Brenner MB, (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22: 817-890.
10. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
11. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, et al. (1999) Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163: 4647-4650.
12. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, et al. (1999) Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 163: 2373-2377.
13. Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, et al. (2000) alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol 199: 37-42.
14. Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, et al. (2003) Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 21 (Suppl 2): S48-54.
15. Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, et al. (2003) CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 197: 1051-1057.
16. Lang GA, Exley MA, Lang ML, (2006) The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 119: 116-125.
17. Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, et al. (1999) CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229.
18. Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, et al. (2007) Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci U S A 104: 3984-3989.
19. Lopes-Carvalho T, Foote J, Kearney JF, (2005) Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 17: 244-250.
20. Grimaldi CM, Michael DJ, Diamond B, (2001) Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167: 1886-1890.
21. Li Y, Li H, Weigert M, (2002) Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 195: 181-188.
22. Wither JE, Loh C, Lajoie G, Heinrichs S, Cai YC, et al. (2005) Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol 175: 4309-4319.
23. Rolf J, Motta V, Duarte N, Lundholm M, Berntman E, et al. (2005) The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol 174: 4821-4827.
24. Marino E, Batten M, Groom J, Walters S, Liuwantara D, et al. (2008) Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57: 395-404.
25. Wither JE, Roy V, Brennan LA, (2000) Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB×NZW)F(1) mice. Clin Immunol 94: 51-63.
26. Yang JQ, Singh AK, Wilson MT, Satoh M, Stanic AK, et al. (2003) Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol 171: 2142-2153.
27. Qian Y, Wang H, Clarke SH, (2004) Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 172: 625-635.
28. Yang JQ, Wen X, Kim PJ, Singh RR, (2011) Invariant NKT Cells Inhibit Autoreactive B Cells in a Contact- and CD1d-Dependent Manner. J Immunol 186: 1512-1520.
29. Bendelac A, Hunziker RD, Lantz O, (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 184: 1285-1293.
30. Yang JQ, Wen X, Liu H, Folayan G, Dong X, et al. (2007) Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Arthritis Rheum 56: 1219-1233.
31. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, et al. (1996) Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 26: 2989-2998.
32. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, et al. (2001) The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 7: 1052-1056.
33. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, et al. (2001) Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 7: 1057-1062.
34. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF, (1997) Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 27: 2366-2374.
35. Hao Z, Rajewsky K, (2001) Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 194: 1151-1164.
36. Gray D, MacLennan IC, Bazin H, Khan M, (1982) Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol 12: 564-569.
37. Oliver AM, Martin F, Kearney JF, (1999) IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 162: 7198-7207.
38. Bendelac A, Bonneville M, Kearney JF, (2001) Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1: 177-186.
39. Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, et al. (2009) Role of marginal zone B lymphocytes in invariant NKT cell activation. J Immunol 182: 6105-6113.
40. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H, (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21: 483-513.
41. Sonoda KH, Stein-Streilein J, (2002) CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 32: 848-857.
42. Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, et al. (2005) Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 102: 2010-2015.
43. Chung Y, Kim BS, Kim YJ, Ko HJ, Ko SY, et al. (2006) CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo. Cancer Res 66: 6843-6850.
44. Faunce DE, Sonoda KH, Stein-Streilein J, (2001) MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 166: 313-321.
45. Singh RR, Ebling FM, Albuquerque DA, Saxena V, Kumar V, et al. (2002) Induction of autoantibody production is limited in nonautoimmune mice. J Immunol 169: 587-594.
46. Fan GC, Singh RR, (2002) Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J Exp Med 196: 731-741.
47. Mizuno T, Zhong X, Rothstein TL, (2003) Fas-induced apoptosis in B cells. Apoptosis 8: 451-460.
48. Campos-Martin Y, Colmenares M, Gozalbo-Lopez B, Lopez-Nunez M, Savage PB, et al. (2006) Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells. J Immunol 176: 6172-6179.
49. Sindhava V, Woodman ME, Stevenson B, Bondada S, (2010) Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS ONE 5: e11445.
50. Brummel R, Lenert P, (2005) Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 174: 2429-2434.
51. Pillai S, Cariappa A, (2009) The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 9: 767-777.
52. Yang JQ, Saxena V, Xu H, Van Kaer L, Wang CR, et al. (2003) Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J Immunol 171: 4439-4446.
53. Wither J, Cai YC, Lim S, McKenzie T, Roslin N, et al. (2008) Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther 10: R108.
54. Sireci G, Russo D, Dieli F, Porcelli SA, Taniguchi M, et al. (2007) Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis. Eur J Immunol 37: 425-433.
55. Wermeling F, Lind SM, Jordo ED, Cardell SL, Karlsson MC, (2010) Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J Exp Med 207: 943-952.
56. Novak J, Lehuen A, (2011) Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 53: 263-270.